Related Experiment Videos
Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients
Ruo-Chia Tseng1, Chin-Chu Lee, Han-Shui Hsu
1Department of Pharmacology, National Cheng Kung University, Tainan 70101, Taiwan, ROC.
Abstract:
A HIC1-SIRT1-p53 circular loop in which hypermethylation in cancer 1 (HIC1) represses the transcription of SIRT1 that deacetylates and inactivates p53 thus leading to HIC1 inactivation has been identified in cell and animal models. However, the alteration and prognostic effects of HIC1-SIRT1-p53 circular loop have never been demonstrated in human cancer patients. We examine the HIC1-SIRT1-p53 alterations in 118 lung cancer patients to define their etiological roles in tumorigenesis. We found that patients with lung squamous cell carcinoma with low p53 acetylation and SIRT1 expression mostly showed low HIC1 expression, confirming deregulation of HIC1-SIRT1-p53 circular loop in the clinical model. Interestingly, the expression of deleted in breast cancer 1 (DBC1), which blocks the interaction between SIRT1 deacetylase and p53, led to acetylated p53 in patients with lung adenocarcinoma. However, epigenetic alteration of HIC1 promoter by posttranslational modifications of histones and promoter hypermethylation favoring the compacted chromatin production attenuated the transcriptional induction by acetylated p53. Importantly, lung cancer patients with altered HIC1-SIRT1-p53 circular regulation showed poor prognosis. Our data show the first valid clinical evidence of the deregulation of HIC1-SIRT1-p53 loop in lung tumorigenesis and prognosis. Distinct status of p53 acetylation/deacetylation and HIC1 alteration mechanism result from different SIRT1-DBC1 control and epigenetic alteration in lung squamous cell carcinoma and lung adenocarcinoma.
Insights
The HIC1-SIRT1-p53 loop is deregulated in lung cancer, impacting prognosis. Alterations in this pathway, including p53 acetylation and HIC1 expression, are linked to poor patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- The hypermethylation in cancer 1 (HIC1)-SIRT1-p53 pathway is a known regulatory loop in cancer models.
- Its clinical relevance and prognostic impact in human lung cancer patients remained uncharacterized.
Purpose of the Study:
- To investigate the alterations and prognostic significance of the HIC1-SIRT1-p53 circular loop in human lung cancer.
- To elucidate the distinct mechanisms of HIC1-SIRT1-p53 deregulation in lung squamous cell carcinoma and lung adenocarcinoma.
Main Methods:
- Analysis of HIC1, SIRT1, p53 acetylation, and deleted in breast cancer 1 (DBC1) expression in 118 lung cancer patients.
- Examination of epigenetic modifications, including promoter hypermethylation and histone modifications, of the HIC1 gene.
- Correlation of molecular findings with patient prognosis.
Main Results:
- Deregulation of the HIC1-SIRT1-p53 loop was confirmed in lung cancer patients, with low HIC1 expression correlating with low p53 acetylation and SIRT1 expression in squamous cell carcinoma.
- DBC1 expression influenced p53 acetylation in lung adenocarcinoma, while epigenetic alterations of the HIC1 promoter attenuated its transcriptional induction.
- Altered HIC1-SIRT1-p53 circular regulation was significantly associated with poor prognosis in lung cancer patients.
Conclusions:
- This study provides the first clinical evidence for the deregulation of the HIC1-SIRT1-p53 loop in lung tumorigenesis and its prognostic implications.
- Distinct mechanisms involving SIRT1-DBC1 interaction and epigenetic alterations drive the differential regulation of this pathway in lung squamous cell carcinoma and lung adenocarcinoma.
Related Concept Videos
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
Hedgehog Signaling Pathway